HopeStage
Back to all studies
CompletedNCT00181675

Galantamine compared with placebo for ADHD in adults

About this titleRead the official source — NCT00181675
Medication studyAges 18–58United States
The study in practice

Understand this study

Who was this study for?

This study was for people with ADHD. Listed age limits: 18 years to 58 years. Other eligibility criteria applied.

Listed locations
CambridgeSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2002
Recruitment status
Completed
Enrollment listed in the registry
40
Sponsor
Massachusetts General Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 58 Years
Official registry ID
NCT00181675
Official title
Show the full official title

A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Cambridge

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Massachusetts General Hospital, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including galantamine HBr.

Who was this study for?

This study was for people with ADHD. Listed age limits: 18 years to 58 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies